(Q36316621)

13 August 2017

1 reference

title

Dry powder inhalers for pulmonary drug delivery (English)

1 reference

13 August 2017

1 reference

Frijlink HW

1

1 reference

13 August 2017

De Boer AH

series ordinal

2

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 November 2004

1 reference

Expert Opinion on Drug Delivery

13 August 2017

published in

1 reference

13 August 2017

volume

1

1 reference

13 August 2017

issue

1

1 reference

13 August 2017

page(s)

67-86

1 reference

Pulmonary delivery of peptide drugs: effect of particle size on bioavailability of leuprolide acetate in healthy male volunteers

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

Analgesic efficacy of inhaled morphine in patients after bunionectomy surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

Pulmonary administration of aerosolised fentanyl: pharmacokinetic analysis of systemic delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

A comparison of the efficacy and safety of inhaled corticosteroids in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

Localization of β-adrenoreceptors in mammalian lung by light microscopic autoradiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

The choice of jet nebulizer, nebulizing flow, and addition of albuterol affects the output of tobramycin aerosols

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

Management of pulmonary disease in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

Efficacy and safety of aerosolized tobramycin in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

Nebulized antibiotics in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

Detecting early structural lung damage in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

Dry powder inhalation as a potential delivery method for vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

Mathematical model for the selective deposition of inhaled pharmaceuticals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

Computer simulations of human lung structures for medical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

Deposition patterns of aerosolized drugs within human lungs: effects of ventilatory parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

The local side effects of inhaled corticosteroids: current understanding and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

The effect of budesonide particle mass on drug particle detachment from carrier crystals in adhesive mixtures during inhalation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

The optimal particle size for β-adrenergic aerosols in mild asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

Airmax: a multi-dose dry powder inhaler

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

Lung deposition of salbutamol in healthy human subjects from the MAGhaler dry powder inhaler

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

The effect of flow rate on drug delivery from the Pulvinal, a high-resistance dry powder inhaler.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

The efficacy of a new salbutamol metered-dose powder inhaler in comparison with two other inhaler devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

Disintegration of weak lactose agglomerates for inhalation applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

The effect of carrier surface and bulk properties on drug particle detachment from crystalline lactose carrier particles during inhalation, as function of carrier payload and mixing time.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

Air classifier technology (ACT) in dry powder inhalation. Part 2. The effect of lactose carrier surface properties on the drug-to-carrier interaction in adhesive mixtures for inhalation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

Adhesion of powders for inhalation: an evaluation of drug detachment from surfaces following deposition from aerosol streams

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

Strategies for particle design using supercritical fluid technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

Optimisation of powders for pulmonary delivery using supercritical fluid technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

Stability and aerodynamic behaviour of glucocorticoid particles prepared by a supercritical fluids process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

Improved lung delivery from a passive dry powder inhaler using an Engineered PulmoSphere powder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

Protein inhalation powders: spray drying vs spray freeze drying

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

Biopharmaceutical powders: particle formation and formulation considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

Inulin glasses for the stabilization of therapeutic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

Pulmonary delivery of therapeutic peptides via dry powder inhalation: effects of micronisation and manufacturing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

The role of particle engineering in relation to formulation and de-agglomeration principle in the development of a dry powder formulation for inhalation of cetrorelix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

Physical stability of salmon calcitonin spray-dried powders for inhalation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

Alternative sugars as potential carriers for dry powder inhalations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

Low molecular weight PLA: a suitable polymer for pulmonary administered microparticles?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

Pulmonary delivery of insulin with nebulized DL-lactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

Mucoadhesive beclomethasone microspheres for powder inhalation: their pharmacokinetics and pharmacodynamics evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

Air classifier technology (ACT) in dry powder inhalation. Part 1. Introduction of a novel force distribution concept (FDC) explaining the performance of a basic air classifier on adhesive mixtures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

The relationship between powder inhaler resistance and peak inspiratory conditions in healthy volunteers--implications for in vitro testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

Flow early in the inspiratory manoeuvre affects the aerosol particle size distribution from a Turbuhaler.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

The influence of relative humidity on particulate interactions in carrier-based dry powder inhaler formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

Review of dry powder inhalers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

Ex-vivo product performance of Diskus and Turbuhaler inhalers using inhalation profiles from patients with severe chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

Inhaled human insulin treatment in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

Inhalation of a dry powder tobramycin PulmoSphere formulation in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

Dry powder inhalation of antibiotics in cystic fibrosis therapy: part 2. Inhalation of a novel colistin dry powder formulation: a feasibility study in healthy volunteers and patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

The ideal inhaler: design and characteristics to improve outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

On the use of dry powder inhalers in situations perceived as constrained

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.67

21 January 2018

Identifiers

DOI

10.1517/17425247.1.1.67

1 reference

13 August 2017

1 reference